Single-cell analysis reveal cell-type-specific RNA methylation patterns in breast cancer

Area of Science:

• Oncology
• Molecular Biology
• Immunology

Background:

• RNA methylation plays a crucial role in gene regulation and cellular processes.
• Aberrant RNA methylation patterns are implicated in various cancers, including breast cancer.
• Understanding cell-type-specific methylation is vital for deciphering cancer progression and immune evasion.

Purpose of the Study:

• To investigate cell-type-specific RNA methylation patterns in primary breast cancers versus metastatic lymph nodes.
• To explore the functional roles of RNA methylation in breast cancer progression and immune regulation.

Main Methods:

• Single-cell RNA sequencing (scRNA-seq) data from five breast cancer patients.
• AUCell method for calculating RNA methylation scores; Seurat for cell annotation.
• Differential gene expression, pseudotime, copy number variation, and cell-cell communication analyses.
• Validation using The Cancer Genome Atlas (TCGA) bulk RNA-seq data.

Main Results:

• Metastatic lymph nodes exhibited significantly lower RNA methylation scores than primary tumors, especially in T and B cells.
• Low methylation correlated with increased cell differentiation, epithelial cell malignancy, and reduced immune cell communication.
• Monocytes showed inverse methylation trends; TCGA data stratified patients based on methylation-associated gene expression and survival.

Conclusions:

• RNA methylation is suppressed during breast cancer metastasis.
• This suppression influences cell differentiation, immune communication dynamics, and ultimately, patient outcomes.
• Findings highlight RNA methylation as a potential therapeutic target in metastatic breast cancer.